Allspring Global Investments’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-187,788
Closed -$5.49M 2680
2023
Q3
$5.49M Buy
187,788
+187,076
+26,275% +$6.73M 0.01% 938
2023
Q2
$32K Sell
712
-757
-52% -$28.9K ﹤0.01% 2388
2023
Q1
$50.6K Sell
1,469
-7
-0.5% -$227 ﹤0.01% 2284
2022
Q4
$41.1K Buy
1,476
+97
+7% +$2.57K ﹤0.01% 2387
2022
Q3
$32K Buy
1,379
+804
+140% +$25.7K ﹤0.01% 2500
2022
Q2
$16K Sell
575
-1,627
-74% -$71.1K ﹤0.01% 2531
2022
Q1
$121K Buy
2,202
+465
+27% +$23K ﹤0.01% 2709
2021
Q4
$92K Buy
+1,737
New +$80.6K ﹤0.01% 2780

Other funds holding SGRY

Allspring Global Investments's SGRY Position: Q4 2023 in Review

Allspring Global Investments sold out of Surgery Partners (SGRY) in Q4 2023, closing a stake of 187,788 shares — an estimated $5.49M sold.

Allspring Global Investments first reported a position in SGRY in Q4 2021 and held it in 8 quarters. The position peaked at $5.49M in Q3 2023. 174 funds tracked by Wall St. Rank hold SGRY as of Q4 2023.

  • Allspring Global Investments reported no remaining Surgery Partners position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 187,788 Surgery Partners shares in Q4 2023, an estimated $5.49M.
  • Allspring Global Investments first reported a position in Surgery Partners in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Surgery Partners position peaked at $5.49M in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.